Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353073
What this trial is testing
A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With Pucotenlimab, Lenvatinib, and Temozolomide for Resectable Head and Neck Mucosal Melanoma (PLT-NAT-HNMM-II)
Who this might be right for
Head and Neck Mucosal Melanomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 30